» Articles » PMID: 14676144

Association of the Metabolic Syndrome with History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination Survey

Overview
Journal Circulation
Date 2003 Dec 17
PMID 14676144
Citations 172
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The combination of cardiovascular risk factors known as the metabolic syndrome is receiving increased attention from physicians, but data on the syndrome's association with morbidity are limited.

Methods And Results: Applying National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria, we evaluated 10 357 NHANES III subjects for the 5 component conditions of the metabolic syndrome: insulin resistance, abdominal obesity based on waist circumference, hypertriglyceridemia, low HDL cholesterol (HDL-C), and hypertension, as well as the full syndrome, defined as at least 3 of the 5 conditions. Logistic regression was used to estimate the cross-sectional association of the syndrome and each of its 5 component conditions separately with history of myocardial infarction (MI), stroke, and either MI or stroke (MI/stroke). Models were adjusted for age, sex, race, and cigarette smoking. The metabolic syndrome was significantly related in multivariate analysis to MI (OR, 2.01; 95% CI, 1.53 to 2.64), stroke (OR, 2.16; 95% CI, 1.48 to 3.16), and MI/stroke (OR, 2.05; 95% CI, 1.64 to 2.57). The syndrome was significantly associated with MI/stroke in both women and men. Among the component conditions, insulin resistance (OR, 1.30; 95% CI, 1.03 to 1.66), low HDL-C (OR, 1.35; 95% CI, 1.05 to 1.74), hypertension (OR, 1.44; 95% CI, 1.00 to 2.08), and hypertriglyceridemia (OR, 1.66; 95% CI=1.20 to 2.30) were independently and significantly related to MI/stroke.

Conclusions: These results indicate a strong, consistent relationship of the metabolic syndrome with prevalent MI and stroke.

Citing Articles

Time-restricted eating with or without a low-carbohydrate diet improved myocardial status and thyroid function in individuals with metabolic syndrome: secondary analysis of a randomized clinical trial.

Zheng Y, Wang J, Liu M, Zhou X, Lin X, Liang Q BMC Med. 2024; 22(1):362.

PMID: 39227921 PMC: 11373390. DOI: 10.1186/s12916-024-03595-6.


Metabolic syndrome and cardiovascular disease among adult cancer patients: results from NHANES 2007-2018.

Liu A, Zhang Y, Tian P, Meng T, Chen J, Zhang D BMC Public Health. 2024; 24(1):2259.

PMID: 39164696 PMC: 11337603. DOI: 10.1186/s12889-024-19659-4.


Identification and verification of immune-related genes for diagnosing the progression of atherosclerosis and metabolic syndrome.

Xie Q, Zhang X, Liu F, Luo J, Liu C, Zhang Z BMC Cardiovasc Disord. 2024; 24(1):405.

PMID: 39095691 PMC: 11295872. DOI: 10.1186/s12872-024-04026-3.


The secondary prevention of coronary heart disease in US adults 75 Years and older in daily practice: Results from the National Health and Nutrition Examination Survey 1999-2018 survey.

Zhang Z, Du C, Zhong X, Wang R, Tang L, Liu X Heliyon. 2024; 10(7):e28239.

PMID: 38571641 PMC: 10987917. DOI: 10.1016/j.heliyon.2024.e28239.


Pattern of dyslipidemia and associated factors in coronary artery disease patients in Khyber Pakhtunkhwa: A cross-sectional secondary data analysis.

Hussain A, Zakria M, Ali I, Tariq S, Hussain A, Siraj S Pak J Med Sci. 2023; 39(5):1416-1421.

PMID: 37680793 PMC: 10480735. DOI: 10.12669/pjms.39.5.7382.